People - Institute of Neuroscience - Newcastle University

Dr Brian Moore
Visiting Researcher

Email: brian.moore@ncl.ac.uk
Telephone: +44 (0) 191 256 3332
Fax: ++44(0)191 256 3324
Address: Academic Psychiatry
1st Floor, Building 15
Newcastle General Hospital
Westgate Road
Newcastle upon Tyne
NE4 6BE, UK

Publications

Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatrica Scandinavica 2011, 124(4), 250-261.
El-Badri S, Ashton H, Ferrier I, Moore P. Family illness history, obstetric complications and age of onset in bipolar patients. Open Neuropsychopharmacology Journal 2009, 2, 11-15.
Goswami U, Varma A, Young AH, Gulrajani C, Moore PB, Khastgir U, Sharma AN, Ferrier IN. Determinants of neurocognitive dysfunction in euthynhc bipolar disorder. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
Goswami U, Gulrajani C, Moore PB, Varma A, Young AH, Khastgir U, Sharma AN, Ferrier IN. Neurocognitive decline in bipolar mood disorder role of mood stabilizers. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
Lloyd A, Harriram H, Thompson JM, Ferrier IN, Young AH, McAllister V, Moore PB. White matter abnormalities in euthymic subjects with bipolar affective disorder. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
Goswami U, Sharma AN, Khastgir U, Thompson JM, Moore PB, Young AH, Ferrier, symptomatically IN2001NeurocognitivestatusintheimprovedBipolarPatients. Journal of Psychopharmacology. 2001, (15 (Suppl):A66).
Goswami U, Sharma AN, Khastgir U, Thompson JM, Moore PB, Young AH, Ferrier IN. Neuro-Logical Soft Signs in Euthymic Bipolar Disorder. Journal of Psychopharmacology 2001, (15(suppl):A20).
Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA. Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dementia and Geriatric Cognitive Disorders 2000, 11(2), 66-69.

Institute of Neuroscience
Newcastle Biomedicine
Newcastle University, Newcastle upon Tyne
NE1 7RU, United Kingdom.
Email Webmaster

Newcastle University

Institute of Neuroscience

Dr Brian Moore Visiting Researcher

Dr Brian Moore
Visiting Researcher